Analysis of T102C 5HT2A polymorphism in Brazilian psychiatric inpatients: Relationship with suicidal behavior

Cellular and Molecular Neurobiology

Volumn 22, Issue 5-6, 2002, Pages 813-817

  Correa, H ^a   De Marco, L ^a   Boson, W ^a   Viana, M M ^a   Lima, V F S ^a   Campi Azevedo, A C ^a   Noronha, J C M ^a   Guatimosim, C ^a   Romano Silva, Marco A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

5 HT2A polymorphism; Serotonin; Suicide

Indexed keywords

CYTOSINE; SEROTONIN 2A RECEPTOR; THYMINE; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; SEROTONIN; SEROTONIN RECEPTOR;

ANAMNESIS; ARTICLE; BRAZIL; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL PATIENT; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR; AGE; BRAIN LEVEL; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MAJOR DEPRESSION; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; SEX DIFFERENCE; SUICIDE;

AGE FACTORS; BRAIN CHEMISTRY; DEPRESSIVE DISORDER, MAJOR; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN; SEX FACTORS; SUICIDE;

EID: 0036976124     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021873411611     Document Type: Article

References (14)

1. Asberg, M. (1997). Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid study. Ann. N.Y. Acad. Sci. 836:158-181.
2. Arango, V., Underwood, M. D., and Mann, J. J. (1997). Postmorten findings in suicide victims: Implications for in vivo imaging studies. Ann. N.Y. Acad. Sci. 836:269-287.
3. Correa, H., Duval, F., Mokrani, M. C., Bailey, P., Tremeau, F., Staner, L., Diep, T. S., Crocq, M. A., and Macher, J. P. (2002). Serotonergic function and suicidal behavior in schizophrenia. Schizophrenia Res. 56:75-85.
4. Correa, H., Duval, F., Mokrani, M. C., Bailey, P., Tremeau, F., Staner, L., Diep, T. S., Hode, Y., Crocq, M. A., and Macher, J. P. (2000). Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res. 93:189-199.
5. Diekstra, R. F. W. (1996). Epidemiologie du suicide. L'Encephale: Sp IV. 15-18.
6. Du, L., Bakish, D., Lapierre, Y. D., Ravindran, A. V., and Hrdina, P. D. (2000). Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am. J. Med. Genet. 96:56-60.
7. Goodal E. M., Cowen, J., Franklin, M., and Silverstone, T. (1993). Ritanserin attenuates anorectic, endocrine and thermic responses to D-fenfluramine in human volunteers. Psychopharmacoloy 112:461-466.
8. Mann, J. J. (1998). The neurobiology of suicide. Nat. Med. 4:25-30.
9. Ohara, K., Nagai, M., Tani, K., Tsukamoto, T., and Ohara, K. (1999). Schizophrenia and the serotonin-2A receptor promoter polymorphism. Psychiatry Res. 85:221-224.
10. Palazidou, E., Stephenson, T, Butler, J., Coskeran, P., Chambers, S., and McGregor, A. (1995). Evidence for 5-HT1A receptor involvement in the control of prolactin secretion in man. Psychopharmacology 119:311-314.
11. Pandey, G. N. (1997). Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies. Ann. N.Y. Acad. Sci. 836:182-183.
12. Roy, A. (1997). Genetics of suicides. Family studies and molecular genetics. Ann. N.Y. Acad. Sci. 836:135-157.
13. Turecki, G., Briere, R., Antonetti, T., Lesage, A. D., Seguin, M., Chaky, N., Vanier, C., Alda, M., Joober, R., Benkelfat, C., and Rouleau, G. A. (1999). Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmorten brain samples from subjects who did or did not commit suicide. Am. J. Psychiatry. 156:1456-1458.
14. Zhang, H. Y., Ishigaki, T., Tani, K., Chen, K., Shih, J. C., Miyasato, K., and Ohara, K. (1997). Serotonin 2A receptor gene polymorphism in mood disorders. Biol. Psychiatry 41:768-773.